Autoantigen Microarray for High-throughput Autoantibody Profiling in Systemic Lupus Erythematosus

Genomics, Proteomics and Bioinformatics

Volumn 13, Issue 4, 2015, Pages 210-218

  Zhu, Honglin ^a,b   Luo, Hui ^a,b   Yan, Mei ^b   Zuo, Xiaoxia ^a   Li, Quan Zhen ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Autoantibody profiling; Biomarker; High throughput assay; Proteomic microarray; Systemic lupus erythematosus (SLE)

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; BIOLOGICAL MARKER; BIOMATERIAL; CELL NUCLEUS ANTIGEN; CHEMOKINE; CYTOKINE; CYTOKINE ANTIBODY; CYTOPLASM PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MATRIX PROTEIN; PHOSPHOLIPID; PROTEIN; PROTEOME; SYNTHETIC PEPTIDE;

ANTIBODY COMBINING SITE; ANTIBODY SPECIFICITY; AUTOIMMUNE DISEASE; BODY FLUID; CEREBROSPINAL FLUID; DATA ANALYSIS; DATA MINING; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULUS; HIGH THROUGHPUT SCREENING; HISTOPATHOLOGY; HUMAN; LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS NEPHRITIS; MENTAL DISEASE; NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; NONHUMAN; PLASMA; PROTEIN MICROARRAY; PROTEIN MODIFICATION; PROTEOMICS; REVIEW; SALVIA; SERUM; SYNOVIAL FLUID; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE SPECIFICITY; WESTERN BLOTTING; BLOOD; IMMUNOLOGY; PROCEDURES; SALIVA;

AUTOANTIBODIES; AUTOANTIGENS; BIOMARKERS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SALIVA; SYNOVIAL FLUID;

EID: 84944392826     PISSN: 16720229     EISSN: 22103244     Source Type: Journal    
DOI: 10.1016/j.gpb.2015.09.001     Document Type: Review

References (55)

1. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
2. Rahman A., Isenberg D.A. Systemic lupus erythematosus. N Engl J Med 2008, 358:929-939.
3. Liu Z., Davidson A. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med 2012, 18:871-882.
4. Giles I., Putterman C. Autoantibodies and other biomarkers - pathological consequences (1). Lupus 2008, 17:241-246.
5. Sherer Y., Gorstein A., Fritzler M.J., Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2004, 34:501-537.
6. Yaniv G., Twig G., Shor D.B., Furer A., Sherer Y., Mozes O., et al. A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients. Autoimmun Rev 2015, 14:75-79.
7. Arbuckle M.R., McClain M.T., Rubertone M.V., Scofield R.H., Dennis G.J., James J.A., et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003, 349:1526-1533.
8. Heinlen L.D., McClain M.T., Merrill J., Akbarali Y.W., Edgerton C.C., Harley J.B., et al. Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis Rheum 2007, 56:2344-2351.
9. Gualtierotti R., Biggioggero M., Penatti A.E., Meroni P.L. Updating on the pathogenesis of systemic lupus erythematosus. Autoimmun Rev 2010, 10:3-7.
10. Rekvig O.P., Putterman C., Casu C., Gao H.X., Ghirardello A., Mortensen E.S., et al. Autoantibodies in lupus: culprits or passive bystanders?. Autoimmun Rev 2012, 11:596-603.
11. Kurien B.T., Scofield R.H. Autoantibody determination in the diagnosis of systemic lupus erythematosus. Scand J Immunol 2006, 64:227-235.
12. Ippolito A., Wallace D.J., Gladman D., Fortin P.R., Urowitz M., Werth V., et al. Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity. Lupus 2011, 20:250-255.
13. Haab B.B., Dunham M.J., Brown P.O. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol 2001, 2. RESEARCH0004.
14. Graham K.L., Robinson W.H., Steinman L., Utz P.J. High-throughput methods for measuring autoantibodies in systemic lupus erythematosus and other autoimmune diseases. Autoimmunity 2004, 37:269-272.
15. Caiazzo R.J., Tassinari O.W., Ehrlich J.R., Liu B.C. Autoantibody microarrays for biomarker discovery. Expert Rev Proteomics 2007, 4:261-272.
16. Yeste A., Quintana F.J. Antigen microarrays for the study of autoimmune diseases. Clin Chem 2013, 59:1036-1044.
17. MacBeath G., Schreiber S.L. Printing proteins as microarrays for high-throughput function determination. Science 2000, 289:1760-1763.
18. Tassinari O.W., Caiazzo R.J., Ehrlich J.R., Liu B.C. Identifying autoantigens as theranostic targets: antigen arrays and immunoproteomics approaches. Curr Opin Mol Ther 2008, 10:107-115.
19. Wang L., Mohan C., Li Q.Z. Arraying Autoantibodies in SLE - lessons learned. Curr Mol Med 2015, 15:456-461.
20. Robinson W.H., DiGennaro C., Hueber W., Haab B.B., Kamachi M., Dean E.J., et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med 2002, 8:295-301.
21. Graham K.L., Vaysberg M., Kuo A., Utz P.J. Autoantigen arrays for multiplex analysis of antibody isotypes. Proteomics 2006, 6:5720-5724.
22. Li Q.Z., Xie C., Wu T., Mackay M., Aranow C., Putterman C., et al. Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J Clin Invest 2005, 115:3428-3439.
23. Li Q.Z., Zhou J., Wandstrat A.E., Carr-Johnson F., Branch V., Karp D.R., et al. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes. Clin Exp Immunol 2007, 147:60-70.
24. Li Q.Z., Zhou J., Lian Y., Zhang B., Branch V.K., Carr-Johnson F., et al. Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes. Clin Exp Immunol 2010, 159:281-291.
25. Li Q.Z., Karp D.R., Quan J., Branch V.K., Zhou J., Lian Y., et al. Risk factors for ANA positivity in healthy persons. Arthritis Res Ther 2011, 13:R38.
26. Wandstrat A.E., Carr-Johnson F., Branch V., Gray H., Fairhurst A.M., Reimold A., et al. Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus. J Autoimmun 2006, 27:153-160.
27. Liu K., Li Q.Z., Yu Y., Liang C., Subramanian S., Zeng Z., et al. Sle3 and Sle5 can independently couple with Sle1 to mediate severe lupus nephritis. Genes Immun 2007, 8:634-645.
28. Fattal I., Shental N., Mevorach D., Anaya J.M., Livneh A., Langevitz P., et al. An antibody profile of systemic lupus erythematosus detected by antigen microarray. Immunology 2010, 130:337-343.
29. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999, 42:599-608.
30. Fragoso-Loyo H., Cabiedes J., Orozco-Narvaez A., Davila-Maldonado L., Atisha-Fregoso Y., Diamond B., et al. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS One 2008, 3:e3347.
31. Hu C., Huang W., Chen H., Song G., Li P., Shan Q., et al. Autoantibody profiling on human proteome microarray for biomarker discovery in cerebrospinal fluid and sera of neuropsychiatric lupus. PLoS One 2015, 10:e0126643.
32. Tucker L.B., Uribe A.G., Fernández M., Vilá L.M., McGwin G., Apte M., et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 2008, 17:314-322.
33. Bennett M., Brunner H.I. Biomarkers and updates on pediatrics lupus nephritis. Rheum Dis Clin North Am 2013, 39:833-853.
34. Haddon D.J., Diep V.K., Price J.V., Limb C., Utz P.J., Balboni I. Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus. Arthritis Res Ther 2015, 17:162.
35. Merola J.F., Chang C.A., Sanchez M.R., Prystowsky S.D. Is chronic cutaneous discoid lupus protective against severe renal disease in patients with systemic lupus erythematosus?. J Drugs Dermatol 2011, 10:1413-1420.
36. Chong B.F., Tseng L.C., Lee T., Vasquez R., Li Q.Z., Zhang S., et al. IgG and IgM autoantibody differences in discoid and systemic lupus patients. J Invest Dermatol 2012, 132:2770-2779.
37. Morimoto A.M., Flesher D.T., Yang J., Wolslegel K., Wang X., Brady A., et al. Association of endogenous antiinterferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 2011, 63:2407-2415.
38. Burbelo P.D., Browne S.K., Sampaio E.P., Giaccone G., Zaman R., Kristosturyan E., et al. Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia. Blood 2010, 116:4848-4858.
39. Price J.V., Haddon D.J., Kemmer D., Delepine G., Mandelbaum G., Jarrell J.A., et al. Protein microarray analysis reveals BAFF-binding autoantibodies in systemic lupus erythematosus. J Clin Invest 2013, 123:5135-5145.
40. Bauer J.W., Baechler E.C., Petri M., Batliwalla F.M., Crawford D., Ortmann W.A., et al. Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med 2006, 3:e491.
41. Culton D.A., Nicholas M.W., Bunch D.O., Zhen Q.L., Kepler T.B., Dooley M.A., et al. Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. J Clin Immunol 2007, 27:53-68.
42. Silverman G.J., Srikrishnan R., Germar K., Goodyear C.S., Andrews K.A., Ginzler E.M., et al. Genetic imprinting of autoantibody repertoires in systemic lupus erythematosus patients. Clin Exp Immunol 2008, 153:102-116.
43. Olsen N.J., Li Q.Z., Quan J., Wang L., Mutwally A., Karp D.R. Autoantibody profiling to follow evolution of lupus syndromes. Arthritis Res Ther 2012, 14:R174.
44. Sekine H., Graham K.L., Zhao S., Elliott M.K., Ruiz P., Utz P.J., et al. Role of MHC-linked genes in autoantigen selection and renal disease in a murine model of systemic lupus erythematosus. J Immunol 2006, 177:7423-7434.
45. Thibault D.L., Graham K.L., Lee L.Y., Balboni I., Hertzog P.J., Utz P.J. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus. Arthritis Res Ther 2009, 11:R112.
46. Tavares R.M., Turer E.E., Liu C.L., Advincula R., Scapini P., Rhee L., et al. The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity. Immunity 2010, 33:181-191.
47. Gutierrez T., Halcomb K.E., Coughran A.J., Li Q.Z., Satterthwaite A.B. Separate checkpoints regulate splenic plasma cell accumulation and IgG autoantibody production in Lyn-deficient mice. Eur J Immunol 2010, 40:1897-1905.
48. Gutierrez T., Mayeux J.M., Ortega S.B., Karandikar N.J., Li Q.Z., Rakheja D., et al. IL-21 promotes the production of anti-DNA IgG but is dispensable for kidney damage in lyn-/- mice. Eur J Immunol 2013, 43:382-393.
49. Mayeux J., Skaug B., Luo W., Russell L.M., John S., Saelee P., et al. Genetic interaction between Lyn, Ets1, and Btk in the control of antibody levels. J Immunol 2015, 195:1955-1963.
50. Huang W., Hu C., Zeng H., Li P., Guo L., Zeng X., et al. Novel systemic lupus erythematosus autoantigens identified by human protein microarray technology. Biochem Biophys Res Commun 2012, 418:241-246.
51. Kinloch A.J., Chang A., Ko K., Henry Dunand C.J., Henderson S., Maienschein-Cline M., et al. Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis. Arthritis Rheumatol 2014, 66:3359-3370.
52. Kattah M.G., Alemi G.R., Thibault D.L., Balboni I., Utz P.J. A new two-color Fab labeling method for autoantigen protein microarrays. Nat Methods 2006, 3:745-751.
53. El Khoury G., Laurenceau E., Chevolot Y., Merieux Y., Desbos A., Fabien N., et al. Development of miniaturized immunoassay: influence of surface chemistry and comparison with enzyme-linked immunosorbent assay and Western blot. Anal Biochem 2010, 400:10-18.
54. Sboner A., Karpikov A., Chen G., Smith M., Mattoon D., Freeman-Cook L., et al. Robust-linear-model normalization to reduce technical variability in functional protein microarrays. J Proteome Res 2009, 8:5451-5464.
55. Kong D.H., Jung J.W., Na K., Jeong S.K., Paik Y.K., Jung S.H., et al. Normalization using a tagged-internal standard assay for analysis of antibody arrays and the evaluation of serological biomarkers for liver disease. Anal Chim Acta 2012, 718:92-98.